Clinical Trial Update: Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sequential FE75C and Docetaxel to Docetaxel plus Cyclophosphamide in HER2-negative, node-positive breast cancer has completed. The summa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• FE75C

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED